Sign In
Buy ONTX
$1.00
+0 (+0%)
At Close: Jul 01, 2024
Onconova Therapeutics, Inc. (ONTX) CEO Steve Fruchtman on Q3 2020 Results - Earnings Call Transcript
10:41pm, Thursday, 12'th Nov 2020
Onconova Therapeutics, Inc. (ONTX) CEO Steve Fruchtman on Q3 2020 Results - Earnings Call Transcript
Onconova Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
04:05pm, Thursday, 12'th Nov 2020
Conference call begins at 4:30 p.m. ET today
Onconova Therapeutics to Provide Corporate Update and Third Quarter 2020 Financial Results on November 12, 2020
08:00am, Thursday, 05'th Nov 2020
Company to host conference call and webcast at 4:30 p.m. Eastern Time on Thursday, November 12 Company to host conference call and webcast at 4:30 p.m. Eastern Time on Thursday, November 12
5 Value Stocks To Watch In The Healthcare Sector
03:46pm, Monday, 17'th Aug 2020
What is a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicator
Onconova Therapeutics, Inc. (ONTX) CEO Steve Fruchtman on Q2 2020 Results - Earnings Call Transcript
11:00pm, Wednesday, 12'th Aug 2020
Onconova Therapeutics, Inc. (NASDAQ:ONTX) Q2 2020 Earnings Conference Call Aug 12, 2020 4:30 PM ET Company Participants Avi Oler - Vice President, Corporate Development and General Counsel Steve Fruch
Onconova Therapeutics: Q2 Earnings Insights
08:37pm, Wednesday, 12'th Aug 2020
Shares of Onconova Therapeutics (NASDAQ:ONTX) decreased 1.89% in after-market trading after the company reported Q2 results.Quarterly Results Earnings per share rose 93.33% over the past year to ($0.0
Onconova Therapeutics Highlights Corporate Progress and Reports Second Quarter 2020 Financial Results
08:05pm, Wednesday, 12'th Aug 2020
* INSPIRE Phase 3 trial survival events reached * Topline data anticipated Q3-2020Conference call and webcast scheduled today, August 12, at 4:30 p.m. ETNEWTOWN, Pa., Aug. 12, 2020 (GLOBE NEWSWIRE) -
Onconova Therapeutics to Provide Corporate Update and Second Quarter 2020 Earnings on August 12, 2020
12:00pm, Friday, 07'th Aug 2020
Company to host conference call and webcast at 4:30 p.m. Eastern Time on Wednesday, August 12NEWTOWN, Pa., Aug. 07, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage
Onconova Therapeutics Announces Compliance with Nasdaq Bid Price Requirement
12:00pm, Tuesday, 04'th Aug 2020
NEWTOWN, Pa., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat canc
Onconova (ONTX) to Report Q2 Earnings: What's in the Offing?
03:52pm, Monday, 03'rd Aug 2020
Investors will focus on pipeline updates when Onconova (ONTX) reports Q2 results.
Bristol Myers Squibb NDA, And Other News: The Good, Bad And Ugly Of Biopharma
03:52pm, Thursday, 30'th Jul 2020
Bristol Myers Squibb resubmits multiple myeloma therapy application. Onconova reports progress of INSPIRE trial data analysis.
Topline INSPIRE Results are Expected by the End of the Third Quarter of 2020NEWTOWN, Pa., July 29, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutica
Onconova And The Conflict Lurking Beneath The Hype
10:14am, Wednesday, 29'th Jul 2020
Onconova has a pivotal readout in a Phase 3 trial for Rigosertib (named INSPIRE) in Myelodysplastic Syndrome due to read out in 2H2020.
Onconova Therapeutics Submits Application for Rigosertib to Participate in Federally Funded Human Studies in COVID-19 Disease
12:00pm, Monday, 27'th Jul 2020
Preclinical experiments with rigosertib in cellular models demonstrate marked inhibition of SARS-CoV-2 replicationNEWTOWN, Pa., July 27, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: O
NEWTOWN, Pa., July 23, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat canc
